Dabigatran Etexilate - NDC Database (Page 2)

32 records found
Page:First Page2
60505-4348 Feb 13, 2024
Dabigatran Etexilate 150 mg Oral Capsule by Apotex Corp.
60505-4349 Feb 13, 2024
Dabigatran Etexilate 110 mg Oral Capsule by Apotex Corp.
60687-744 Apr 01, 2023
Dabigatran Etexilate 75 mg Oral Capsule by American Health Packaging
60687-752 Apr 01, 2023
Dabigatran Etexilate 150 mg Oral Capsule by American Health Packaging
62332-634 Jun 14, 2024
Dabigatran Etexilate 75 mg Oral Capsule by Alembic Pharmaceuticals Inc.
62332-635 Aug 13, 2024
Dabigatran Etexilate 110 mg Oral Capsule by Alembic Pharmaceuticals Inc.
62332-636 Jun 14, 2024
Dabigatran Etexilate 150 mg Oral Capsule by Alembic Pharmaceuticals Inc.
67877-474 Jun 20, 2022
Dabigatran Etexilate 75 mg Oral Capsule, Coated Pellets by Ascend Laboratories, LLC
67877-475 Jun 20, 2022
Dabigatran Etexilate 150 mg Oral Capsule, Coated Pellets by Ascend Laboratories, LLC
67877-624 Sep 12, 2025
Dabigatran Etexilate 110 mg Oral Capsule, Coated Pellets by Ascend Laboratories, LLC
72865-272 Aug 01, 2023
Dabigatran Etexilate 75 mg Oral Capsule by Xlcare Pharmaceuticals, Inc.
72865-273 Aug 01, 2023
Dabigatran Etexilate 150 mg Oral Capsule by Xlcare Pharmaceuticals, Inc.
Page:First Page2
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.